<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00959491</url>
  </required_header>
  <id_info>
    <org_study_id>RH-9</org_study_id>
    <nct_id>NCT00959491</nct_id>
  </id_info>
  <brief_title>A Prospective Study of a New Immunological Fecal Occult Blood Test</brief_title>
  <acronym>RLHV</acronym>
  <official_title>A Prospective Study of a New Immunological Fecal Occult Blood Test in Patients Referred for Colonoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Gastroenterology, Cuba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute of Gastroenterology, Cuba</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the investigators study is to evaluate the diagnostic ability of a new&#xD;
      immunological fecal occult blood test in Cuban patients undergoing colonoscopy .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Colorectal cancer is a major cause of cancer deaths in many countries. Therefore, the&#xD;
      importance of screening for the early detection of colorectal cancer is evident. Fecal occult&#xD;
      blood screening is proving to be an effective tool for detecting premalignant adenomas and&#xD;
      colon cancer since the guaiac-based test was introduced in the late 1960s. However, several&#xD;
      immunochemical fecal occult blood tests (IFOBTs) have become commercially available and the&#xD;
      majority of these have demonstrated equal or superior sensitivities and specificities than&#xD;
      the guaiac-based tests. Therefore, IFOBTs are replacing guaiac based tests despite their&#xD;
      higher costs.In this study we evaluate the diagnostic accuracy of a new IFOBT and compare&#xD;
      with the findings on colonoscopy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>October 2009</start_date>
  <completion_date type="Anticipated">November 2010</completion_date>
  <primary_completion_date type="Anticipated">October 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Colonoscopy</condition>
  <condition>Occult Blood</condition>
  <condition>Immunologic Tests</condition>
  <arm_group>
    <arm_group_label>Colonoscopy indication</arm_group_label>
    <description>All outpatients referred to colonoscopy according to inclusion criteria in the specified period time of one year .</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      One fecal sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Residents of Havana City admitted at the investigation center.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients (men or women) that are &gt;18 years of age referred to colonoscopy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Visible rectal bleeding&#xD;
&#xD;
          -  Known diagnosis of inflammatory bowel disease&#xD;
&#xD;
          -  Hematuria&#xD;
&#xD;
          -  Menstruation at the time of obtaining a stool specimen&#xD;
&#xD;
          -  Patients taking medication such as non steroids anti inflammatory drugs and&#xD;
             anticoagulants&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luis C Bertot, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute of Gastroenterology , Havana, Cuba</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institute of Gastroenterology</name>
      <address>
        <city>Havana</city>
        <zip>10400</zip>
        <country>Cuba</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Cuba</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <study_first_submitted>August 13, 2009</study_first_submitted>
  <study_first_submitted_qc>August 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 14, 2009</study_first_posted>
  <last_update_submitted>October 19, 2010</last_update_submitted>
  <last_update_submitted_qc>October 19, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2010</last_update_posted>
  <responsible_party>
    <name_title>Luis Calzadilla Bertot</name_title>
    <organization>National Institute of Gastroenterology</organization>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>Occult Blood</keyword>
  <keyword>Fecal</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

